Evidence map›Paper›PMID 29849055›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

Reduced GABAergic cortical inhibition in aging and depression.

Jennifer I Lissemore, Apoorva Bhandari, Benoit H Mulsant, Eric J Lenze, Charles F Reynolds, Jordan F Karp, Tarek K Rajji, Yoshihiro Noda, Reza Zomorrodi, Etienne Sibille and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review of Emotion Regulation in Late Life Mood Disorders.Journal of psychiatry and brain science · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Jennifer I LissemoreTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Apoorva BhandariTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Benoit H MulsantDepartment of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
Eric J LenzeHealthy Mind Lab, Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
Charles F ReynoldsDepartment of Psychiatry, Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Jordan F KarpDepartment of Psychiatry, Western Psychiatric Institute and Clinic of University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Tarek K RajjiTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Yoshihiro NodaTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Reza ZomorrodiTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Etienne SibilleDepartment of Psychiatry, University of Toronto, Toronto, ON, M5T 1R8, Canada.
Zafiris J DaskalakisTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada.
Daniel M BlumbergerTemerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, M6J 1H4, Canada. daniel.blumberger@camh.ca.
Centre for Addiction and Mental Health · CAUniversity of Toronto · CAGeriatric Research Education and Clinical Center · USUniversity of Pittsburgh Medical Center · USWashington University in St. Louis · US

Funding

3/3-Incomplete Response in Late-Life Depression: Getting to RemissionR01MH083643 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MULSANT, BENOIT H · 2009 to 2013
$1.3M
3/3 Buprenorphine for Late-Life Treatment Resistant DepressionR34MH101365 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI BLUMBERGER, DANIEL M. · 2014 to 2016
$479k
NIMH NIH HHS R01 MH083643NIMH NIH HHS R34 MH101365
6 · The paper itself

Abstract

The neurobiology underlying depression in older adults is less extensively evaluated than in younger adults, despite the putative influence of aging on depression neuropathology. Studies using transcranial magnetic stimulation (TMS), a neurophysiological tool capable of probing inhibitory and excitatory cortical neurotransmission, have identified dysfunctional GABAergic inhibitory activity in younger adults with depression. However, GABAergic and glutamatergic cortical neurotransmission have not yet been studied in late-life depression (LLD). Here, we used single- and paired-pulse TMS to measure cortical inhibition and excitation in 92 LLD patients and 41 age-matched healthy controls. To differentiate the influence of age and depression, we also compared these TMS indices to those of 30 younger depressed adults and 30 age- and sex-matched younger healthy adults. LLD patients, older healthy adults, and younger depressed adults demonstrated significantly lower GABA

Indexed as

AdultAgedAgingCortical ExcitabilityDepressionFemaleGABAergic NeuronsHumansMaleMiddle AgedMotor CortexNeural InhibitionTranscranial Magnetic Stimulation

Identifiers

PMID29849055
PMCPMC6135847
OpenAlexW2803977806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.